Try our Advanced Search for more refined results
Searching dockets in Dabdoub Law Firm x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Racketeer/Corrupt Organization | California Central
Supplement (Motion related)
SUPPLEMENT BRIEF IN FURTHER OPPOSITION TO DEFENDANTS' MOTION FOR SANCTIONS FOLLOWING THE AUGUST 28, 2026 HEARING ON DEFENDANTS' MOTION filed by Plaintiffs MSP Recovery Claims PROV, Series LLC, MSP Recovery Claims, Series LLC, MSPA CLAIMS 1, LLC. (Attachments: # 1 Exhibit A - MSP Opposition to Sanctions Hearing Presentation, # 2 Exhibit B - 09.03.2026 Email cover letter to re-production of volumes MSP_VOL026 through MSP_VOL037)(Portal, Janpaul)
Supplement re Discovery Matter Sanctions on Discovery Matter
REQUEST to Supplement Motion for Sanctions re MOTION for Sanctions Pursuant to Rule 37 231 , REQUEST for Sanctions Rule 37 and Court's Inherent Authority filed by Defendants Amgen Inc., Chronic Disease Fund, Inc., Onyx Pharmaceuticals, Inc., Onyx Therapeutics, Inc.. (Attachments: # 1 Declaration Second Supplemental Declaration of Sean A. Commons, # 2 Declaration Declaration of Scott Leon Bailey)(Commons, Sean)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.